World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
94
Citations
27758
World Ranking
2039
National Ranking
1111

Medicine

D-Index
94
Citations
27730
World Ranking
10596
National Ranking
5447

Overview

Benjamin Bonavida is affiliated with the University of California, Los Angeles in the United States. Their research spans several interconnected fields including Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these broader domains, their work encompasses Immunology, Molecular Biology, Oncology, Pathology and Forensic Medicine, and Cancer Research.

The scientist's research topics focus significantly on areas such as Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cancer Mechanisms and Therapy, Immune cells in cancer, Melanoma and MAPK Pathways, and Monoclonal and Polyclonal Antibodies Research.

Benjamin Bonavida's recent publications include:

  • Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability, 2022, published in Drug Resistance Updates
  • Regulation of T Cells in Cancer by Nitric Oxide, 2021, published in Cells
  • Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs, 2020, published in Biochemical Pharmacology
  • The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment, 2022, published in Cancers
  • Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1, 2024, published in Cancers

The scientist frequently publishes in several venues, including:

  • Critical Reviews™ in Oncogenesis
  • Critical Reviews in Immunology
  • Cancers
  • Cells
  • International Journal of Molecular Sciences

Their collaborative network includes recurring coauthors such as Massimo Libra, Silvia Vivarelli, Luca Falzone, Apostolos Zaravinos, and Inesa Navasardyan.

Best Publications

  • Transcription factor YY1: structure, function, and therapeutic implications in cancer biology

    S Gordon;G Akopyan;H Garban;B Bonavida

  • Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs.

    Aicha Demidem;Tammy Lam;Steve Alas;Kandasamy Hariharan

  • Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention

    Samantha Kaufhold;Benjamin Bonavida

  • Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.

    Steve Alas;Benjamin Bonavida

  • Inhibition of Interleukin 10 by Rituximab Results in Down-Regulation of Bcl-2 and Sensitization of B-cell Non-Hodgkin’s Lymphoma to Apoptosis

    Steve Alas;Christos Emmanouilides;Benjamin Bonavida

  • Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention

    Ali R Jazirehi;Benjamin Bonavida

  • Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.

    Steve Alas;Benjamin Bonavida

  • Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications

    Anna Shvartsur;Benjamin Bonavida

  • Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency.

    Elizabeth Grimm;Benjamin Bonavida

  • Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.

    Pei-Feng Hu;Lance E. Hultin;Patricia Hultin;Mary Ann Hausner

  • Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival.

    Eric Sanchez;Mingjie Li;Alex Kitto;Jennifer Li

  • Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

    B. C. Potts;M. X. Albitar;K. C. Anderson;S. Baritaki

  • Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.

    Nicolò Borsellino;Arie Belldegrun;Benjamin Bonavida

  • Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.

    Ali R. Jazirehi;Mario I. Vega;Devasis Chatterjee;Lee Goodglick

  • Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.

    B Bonavida

  • Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.

    S C Wright;A Jewett;R Mitsuyasu;B Bonavida

  • Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer

    Gang Ren;Stavroula Baritaki;Himangi Marathe;Jingwei Feng

  • Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.

    Ali R Jazirehi;Sara Huerta-Yepez;Genhong Cheng;Benjamin Bonavida

  • Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis.

    Golaun Odabaei;Devasis Chatterjee;Ali R. Jazirehi;Lee Goodglick

  • Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy

    Ali R. Jazirehi;Mario I. Vega;Benjamin Bonavida

Frequent Co-Authors

Anahid Jewett
Anahid Jewett University of California, Los Angeles
Otoniel Martínez-Maza
Otoniel Martínez-Maza University of California, Los Angeles
Jonathan W. Said
Jonathan W. Said University of California, Los Angeles
Demetrios A. Spandidos
Demetrios A. Spandidos University of Crete
Rogelio Hernández-Pando
Rogelio Hernández-Pando Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Elizabeth A. Grimm
Elizabeth A. Grimm The University of Texas MD Anderson Cancer Center
Michael C. Fishbein
Michael C. Fishbein University of California, Los Angeles
Kazuo Umezawa
Kazuo Umezawa Aichi Medical University
Eli E. Sercarz
Eli E. Sercarz Torrey Pines Institute For Molecular Studies
John L. Fahey
John L. Fahey University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

An academic background in Biology or Biochemistry opens doors to diverse online degrees and healthcare career specializations. Aspiring professionals may consider online programs that build on their scientific foundation and lead to in-demand roles in patient care, nutrition, and nursing.

For those interested in advanced practice nursing, options like the best online post master's pmhnp programs and the shortest online nurse practitioner program allow students to specialize further and enter the workforce quickly. These programs are designed for graduates seeking flexibility and the opportunity to deliver high-quality care in clinical or community settings.

Nutrition is another promising pathway. Those with a biochemistry background may pursue the best online registered dietitian programs, helping clients make evidence-based health decisions and manage medical conditions through diet.

Registered nurses looking to advance or specialize can explore online rn to bsn programs for expanded career mobility and increased earning potential.

These related degrees offer flexible learning and career-advancement pathways for students with strong biology or biochemistry foundations.

Best Scientists Citing Benjamin Bonavida

Trending Scientists